Cargando…
Sargassum fusiforme Alginate Relieves Hyperglycemia and Modulates Intestinal Microbiota and Metabolites in Type 2 Diabetic Mice
Sargassum fusiforme alginate (SF-Alg) possess many pharmacological activities, including hypoglycemic and hypolipidemic. However, the hypoglycemic mechanisms of SF-Alg remain unclear due to its low bioavailability. In this study, we evaluated the therapeutic effect of SF-Alg on high-fat diet (HFD)/s...
Autores principales: | Liu, Jian, Wu, Siya, Cheng, Yang, Liu, Qiuhui, Su, Laijin, Yang, Yue, Zhang, Xu, Wu, Mingjiang, Choi, Jong-il, Tong, Haibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398017/ https://www.ncbi.nlm.nih.gov/pubmed/34445047 http://dx.doi.org/10.3390/nu13082887 |
Ejemplares similares
-
Therapeutic and nutraceutical potentials of a brown seaweed Sargassum fusiforme
por: Liu, Jian, et al.
Publicado: (2020) -
Sargassum fusiforme polysaccharide attenuates high‐sugar–induced lipid accumulation in HepG2 cells and Drosophila melanogaster larvae
por: He, Dan, et al.
Publicado: (2021) -
The complete chloroplast genome of Sargassum fusiforme
por: Liu, Tao, et al.
Publicado: (2020) -
Study on the Anti-Adenovirus Mechanism of Sargassum fusiforme
por: Feng, Guanrong, et al.
Publicado: (2022) -
First Draft Genome Assembly of the Seaweed Sargassum fusiforme
por: Wang, Shengqin, et al.
Publicado: (2020)